Russia conducting monkeypox vaccine preclinical studies

Russia conducting monkeypox vaccine preclinical studies

The specialists of the Russian Federal Medical-Biological Agency (FMBA) have developed a modern monkeypox vaccine, which is currently undergoing preclinical studies, the head of the FMBA, Veronika Skvortsova, said on Tuesday.

"A modern vector-based vaccine against monkeypox has been developed, it is now already undergoing preclinical studies," Skvortsova said at the Eastern Economic Forum (EEF) during a panel session "Drug Security: Strategic Course of Social Policy in the Far East. Challenges and Opportunities."

2035 views
We use cookies and collect personal data through Yandex.Metrica in order to provide you with the best possible experience on our website.